PhD Candidate in Chemistry
University of Wisconsin–Madison · Expected May 2026
- Advanced mass spectrometry for therapeutic protein characterization and quantitative proteomics.
- Instrument manager for Bruker timsTOF fleX MALDI-2 system.
Analytical Chemist · Mass Spectrometry
PhD candidate in Chemistry at the University of Wisconsin–Madison specializing in advanced mass spectrometry, therapeutic protein characterization, and quantitative proteomics.
Academic background in chemistry with specialized training in analytical chemistry and mass spectrometry.
University of Wisconsin–Madison · Expected May 2026
National Taiwan University · June 2020
My work centers on developing and applying advanced mass spectrometry workflows to characterize therapeutic proteins, decode complex proteomes, and elucidate biomolecular structures in biological systems.
Middle-down and top-down mass spectrometry workflows for monoclonal antibodies, antibody–drug conjugates, and charge variants, with an emphasis on sequence coverage and site-specific PTM localization.
Isobaric tagging-based quantitative proteomics and diaPASEF/dia workflows to assess the efficacy of RIPK1-targeting degraders and other targeted protein degradation strategies across cell models.
LC–MS and MALDI-IM-MS methods for structural elucidation of metabolites, lipids, and glycans from FFPE and fresh-frozen tissues, supported by in-house spectral library development.
Design of dual-polarity MALDI matrices and high-throughput enrichment workflows to enable sensitive and versatile ionization across diverse biomolecular classes and tissue types.
A selection of publications and a patent spanning analytical chemistry, mass spectrometry, and biomolecular structure characterization. For a complete list, please see my CV or Google Scholar profile.
Proteome-wide secretome profiling; featured as supplemental cover article.
High-throughput phospholipid enrichment and MALDI-2 with ion mobility MS.
Design of dual-polarity MALDI matrices enabling positive/negative ion detection.
US patent on novel MALDI matrix technology.
Experience spanning biopharmaceutical industry and academic research, with a focus on analytical chemistry and mass spectrometry method development.
Regeneron Pharmaceuticals, Inc., Tarrytown, NY · May 2025 – Aug 2025
University of Wisconsin–Madison, Department of Chemistry · Jan 2022 – Present
National Taiwan University · Jul 2018 – Feb 2021
I enjoy mentoring, instrument stewardship, and organizing scientific events to support collaborative research communities.
Selected recognitions for research excellence, presentations, and academic performance.
GSFLC, UW–Madison · 2025
MSACL · 2024
UW–Madison · 2024
NTU · 2021
NTU · 2020
8th AOMSC · 2020
For a detailed overview of my education, research experience, publications, and service, please see my full CV.
I am open to opportunities in analytical R&D, biopharmaceutical industry roles, and collaborations involving advanced mass spectrometry and protein characterization.